1255945-85-7 Usage
Uses
Used in Organic Synthesis:
2-(4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetic acid is used as a building block in organic synthesis for the construction of complex organic molecules. Its unique structure allows for the formation of new chemical entities through various synthetic routes, contributing to the development of novel compounds with potential applications in different industries.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2-(4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetic acid is utilized as a key intermediate in the synthesis of pharmaceuticals. Its incorporation into drug molecules can lead to the discovery of new therapeutic agents with improved pharmacological properties, such as enhanced potency, selectivity, and reduced side effects.
Used in Pharmaceutical Development:
2-(4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetic acid is employed in the development of pharmaceuticals as a precursor for the synthesis of bioactive compounds. Its potential applications in drug discovery include the creation of new drugs for the treatment of various diseases, as well as the improvement of existing medications through structural modifications.
Used in the Study of Cellular Processes:
In biological research, 2-(4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetic acid may be used as a tool compound to investigate cellular processes. Its interaction with cellular targets can provide insights into the mechanisms of action of various biological pathways, aiding in the understanding of disease mechanisms and the identification of potential therapeutic targets.
Used in Cross-Coupling Reactions:
The boron atom in 2-(4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetic acid makes it a suitable candidate for cross-coupling reactions, a widely used method in organic chemistry for the formation of carbon-carbon bonds. 2-(4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetic acid can be employed as a reactant in such reactions, enabling the synthesis of a variety of organic molecules with diverse structural features and potential applications.
Overall, 2-(4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetic acid is a versatile and important chemical compound with potential applications in various fields, including organic synthesis, medicinal chemistry, pharmaceutical development, biological research, and cross-coupling reactions. Its unique structure and properties make it a valuable asset in the advancement of scientific knowledge and the development of innovative solutions in these areas.
Check Digit Verification of cas no
The CAS Registry Mumber 1255945-85-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,5,9,4 and 5 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1255945-85:
(9*1)+(8*2)+(7*5)+(6*5)+(5*9)+(4*4)+(3*5)+(2*8)+(1*5)=187
187 % 10 = 7
So 1255945-85-7 is a valid CAS Registry Number.
1255945-85-7Relevant academic research and scientific papers
MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME
-
Paragraph 0387; 0392-0393, (2014/07/22)
Described herein are monomers capable of forming a biologically useful multimer when in contact with one, two, three or more other monomers in an aqueous media. In one aspect, such monomers may be capable of binding to another monomer in an aqueous media (e.g. in vivo) to form a multimer, (e.g. a dimer). Contemplated monomers may include a ligand moiety, a linker element, and a connector element that joins the ligand moiety and the linker element. In an aqueous media, such contemplated monomers may join together via each linker element and may thus be capable of modulating one or more biomolecules substantially simultaneously, e.g., modulate two or more binding domains on a protein or on different proteins.
PYRIDYLUREA DERIVATIVES AND THEIR THERAPEUTIC USE
-
Page/Page column 24, (2010/12/17)
Compounds of formula (IA) are inhibitors of p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract formula (IA). wherein R 1 is a radical of formula (IIA), (IIB), or (IIC); wherein m is 0 or 1; T is N or CH; R 2a, R 2b, R 2c are independently selected from H, halogen and C1 -C6 alkyl; R3 is H or F; R4 is -CH3; -C2 H5; -CH2OH, CH2SCH3; - SCH3 or -SC2H5; R5 is -CH3 or -C2H5; R6 is H, or represents one or more 10 substituents, each independently selected from C1 -C6 alkyl, hydroxy, halogen, and radicals of formulae (IIIA), (IIIB) and (IIIC):IA)(IIIB)(IIIC); wherein R61a and R61b are independently H or C1-C6 alkyl, or R61a and R61b taken together with the nitrogen to which they are attached to form a 6-membered 15 heterocyclic ring optionally containing a further heteroatom selected from N and O; n is 0, 1 or 2; p is 1 or 2; R7 is H or F; and R8 is H or CONH2.
